Autonomix Medical Company Insiders

Autonomix Medical Management Team Effectiveness

The company has return on total asset (ROA) of (1.5931) % which means that it has lost $1.5931 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.5241) %, meaning that it created substantial loss on money invested by shareholders. Autonomix Medical's management efficiency ratios could be used to measure how well Autonomix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.1 in 2026. Return On Capital Employed is likely to drop to -1.35 in 2026. Non Current Assets Total is likely to rise to about 237.9 K in 2026, whereas Total Assets are likely to drop slightly above 6.1 M in 2026. Common Stock Shares Outstanding is likely to drop to about 1.5 M in 2026Autonomix Medical Common shows 6.71 percent of its outstanding shares held by insiders and 4.77 percent owned by other corporate entities. Some institutional investors establish a significant position in stocks such as Autonomix Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Autonomix Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Autonomix Medical Workforce Comparison

Autonomix Medical Insider Trading

Autonomix Medical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Autonomix Medical Common often depends on how effective the management is. Autonomix Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Autonomix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Autonomix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Autonomix Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Autonomix Medical Common. Check Autonomix Medical's Beneish M Score to see the likelihood of Autonomix Medical's management manipulating its earnings.

When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.